Synendos Therapeutics
FranceEntry
2021
Hold
5yr
Status
Active
Who owns Synendos Therapeutics?
Synendos Therapeutics is a French Biotech company, currently owned by Ysios Capital Partners since 2021 and Sunstone Life Science Ventures.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Ysios Capital PartnersYsios BioFund III · 2020 · Life Sciences VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2020 · present
Ysios Capital PartnersActive
2021 · present(5yr) · Ysios BioFund III · 2020 · Life Sciences VC
More from Ysios BioFund III
Other portfolio companies in the same fund.
CH
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Synendos Therapeutics?
Synendos Therapeutics is currently owned by Ysios Capital Partners and Sunstone Life Science Ventures, through Ysios BioFund III, since 2021.
When did Ysios Capital Partners and 1 other acquire Synendos Therapeutics?
Ysios Capital Partners and 1 other acquired Synendos Therapeutics in 2021.
Who has owned Synendos Therapeutics over time?
Synendos Therapeutics has been through 2 private-equity ownership periods: Sunstone Life Science Ventures · via Sunstone Life Science Ventures IV · since 2020; Ysios Capital Partners · via Ysios BioFund III · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue